Related Product Information for
Cytotoxicity assay kit
Background/Introduction: Cytolytic activity is an important process for eliminating intracellular pathogens and cancer cells. This process is accomplished through various immune effector mechanisms including natural killer (NK) leukocytes. NK activity is facilitated by non-specifically lysing infected targets through the use of NK receptors, or the FcgammaII (CD16) receptor, recognizing IgG bound to specific antigens on the target cell surface1. NK cells may also induce apoptosis in target cells. The activity of natural killer cells, and their effect on target cells, is frequently studied in immunomodulation experiments. Older methods to assess NK cytolytic activity include measuring the release of lactate dehydrogenase, and more commonly, the release of radioactive 51Cr from lysed target cells1. Unfortunately, these techniques have several drawbacks. Traditional enzyme-release assays are often skewed by the large number of necrotic effector cells. Problems associated with 51Cr release methods include high spontaneous leakage resulting in high backgrounds, high cost, short half-life, and the health risks due to exposure to radioactive material2. Beyond these limitations, these assays frequently underestimate the true level of cytotoxicity, as they are unable to detect early-stage apoptotic cells. Flow cytometric assays have been developed to overcome some of the difficulties associated with older assays like lactate dehydrogenase and 51Cr release assays. Once such early version involved the detection of NK cytotoxicity activity by staining target cells with the green fluorescent dye, F-18, in combination with the DNA intercalating dye, propidium iodide3. Since then, a red fluorescent membrane dye, PKH-26, has been used in preference to F-18, and in combination with the viability probe, TO-PRO-3 iodide4-7. However, despite correlations of greater than 95% when compared with the 51Cr release assay1, the PKH-26 method is problematic. It is difficult to use at a constant concentration, leading to unreliable staining, and the staining procedure requires multiple steps, often decreasing the viability of the target cells. More recently, the problems with older flow cytometric assays were overcome with the use of 5(6)-carboxyfluorescein diacetate N-succinimidyl ester (CFSE), a green fluorogenic reagent that diffuses into target cells and covalently binds to primary amino groups on intracellular molecules8. Intracellular esterases quickly cleave the acetate groups from the dye, thus converting it to its green fluorescent form. Any unbound reagent diffuses back out of the cell. Building upon these techniques, has developed the Total Cytotoxicity & Apoptosis Assay, a flow cytometric assay combining the green fluorescing cellular stain, (CFSE), with a red fluorescing live/dead stain, 7-aminoactinomycin D (7-AAD), and SR-FLICA® apoptosis detection reagent to concurrently quantify caspase-positive cells. The assay can be used to determine total cytotoxicity in the form of apoptosis and necrosis. It will quantify 4 populations of cells: live; early apoptotic; late apoptotic; and necrotic cells within a single sample tube. While other methods often underestimate the true level of cytotoxicity, Total Cytotoxicity & Apoptosis Assay is the best method to accurately quantify cell death because it can detect cells in early apoptosis. This often reveals a significant percentage of cells that are 7-AAD negative (indicating that they are alive and do not have compromised membranes), but are SRFLICA positive (meaning that they are becoming apoptotic and dying and have active caspase enzymes). In the assay, CFSE is first used to label the target cell population green (Figure 4). The unstained effector cells are then added and incubated with the target cells (referred to as the Effector:Target, or 'E:T' mixture, Figure 5). As all the target cells are initially labeled with green fluorescing CFSE, and the effector cells are not, these two populations can be easily distinguished (Figure 8). Apoptotic target cells can then be identified by labeling with the second reagent, SR-FLICA (Figure 6). SR-FLICA is an orange/red fluorescent poly caspase inhibitor, SR-VAD-FMK, which binds to active caspase enzymes up-regulated for apoptosis9. Upon completion of the E:T incubation (which includes exposure to the apoptosis detection reagent), the last reagent, 7-AAD, is added to stain all dead cells red by binding to the DNA of membrane- compromised cells (Figure 7). With proper compensation and gating of the flow cytometer using the designated instrument controls (Figures 3 and 8-13) researchers can distinguish between target and effector cells, and living, necrotic, and apoptotic cells, and assess the level of cytotoxicity in their samples (Figures 14-15).
ICT's Total
Cytotoxicity Test
can be used
to easily analyze
the activity of
natural killer
(NK) cells. Based
on flow
cytometric data,
the formula
[R2/(R2+R1)] X
100 was used to
calculate cytotoxicity. NK-killed necrotic cells are shown in the maroon line, and
apoptotic cells are shown as the blue line. When added together, the total level
of cell death is calculated as the black line. In this example, cytotoxicity
increased as more NK effector cells were combined with target cells. As the ratio
of Effector:Target-cells increased from 12.5:1 to 100:1 the percentage of target
cells dying increased from 11% to 60%.
As all target cells
were initially
stained green, the
entire population
can be counted in
R3=R2+R1. After the
effector cells and
red live/dead stain
were added, all the
dead target cells
were stained red, shifting them up the Y-axis (R2), clearly distinguishing them
from the live target cells (R1). (Live effector cells are at lower left, dead effector
cells are in upper left). Using the Basic Cytotoxicity Test, the analysis would be
complete (and R2 would be the maroon line above). However, ICT's Total
Cytotoxicity Kit includes an additional caspase reagent to concurrently assess
apoptosis (which is the blue line above). To complete the analysis using the
Total Cytotoxicity Test, further analyze R1 and R2 to isolate apoptotic cells.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.